Adaptive Biotechnologies Corporation
ADPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5.1% | -8.1% | 20.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 59.7% | 55.6% | 68.7% | 68.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -71.9% | -111.2% | -94.6% | -125.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -89.1% | -132.3% | -108% | -134.3% |
| EPS Diluted | -1.08 | -1.56 | -1 | -1.46 |
| % Growth | 30.8% | -56% | 31.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |